Tocilizumab and COVID-19

Dr. Arvinder Soin discusses the use of tocilizumab plus standard
care versus standard care alone in the treatment of moderate to
severe COVID-19-associated cytokine release syndrome. 

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv